A Phase II Study of Paclitaxel+S-1 for previously treated Non-Small Cell Lung Cancer
Phase 2
- Conditions
- Advanced or relapsed Non-Small Cell Lung Cancer
- Registration Number
- JPRN-UMIN000003719
- Lead Sponsor
- Osaka Medical Center for Cancer and Cardiovascular Diseases
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 50
Inclusion Criteria
Not provided
Exclusion Criteria
1)uncontrollablenangina pectoris, arrythmia or heart failure 2)Hystory of active double cancer 3)complication of superior vena cava syndrome 4)complication ofliver cirrhosis 5)Interstitial pneumonaitis on chest x-ray 6)complication ofgastrointestinal bleeding 7)poorly controled diabetes mellitus 8)symptoms of ileus or watery diarrhea 9)Patients with serious infections or susupected infections with fever 10)complication of massive pericardial effusion, ascites or pleural sffusion 11)Pregnant or lactating woman 12)Symptomatic brain metastasis 13)Patients whose participation in the trial is judged to be inappropriate by the attending doctor.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Response rate
- Secondary Outcome Measures
Name Time Method Progression free survival 1-year suvival rate safety